APOE and Alzheimer disease: In conclusion, our analysis from a large population‐based study highlights blood apoE4 levels as a potentially modifiable risk factor for cognitive impairment and could support the development of novel strategies that target individuals who carry the APOE ε4 risk gene for AD.